JHVEPhoto/iStock Editorial via Getty Images Introduction It has been a while since I last rated UnitedHealth Group ( UNH ), as I gave it a buy rating back in October, and since then, the stock has been on a roller -coaster, finally settling nearly 12% higher than my last recommendation. I want to dive into the latest dynamics of the firm and understand if it is still worth buying into today’s mark...
JHVEPhoto/iStock Editorial via Getty Images Introduction It has been a while since I last rated UnitedHealth Group ( UNH ), as I gave it a buy rating back in October, and since then, the stock has been on a roller -coaster, finally settling nearly 12% higher than my last recommendation. I want to dive into the latest dynamics of the firm and understand if it is still worth buying into today’s market. Current Dynamics I’ll just quickly go through the latest earnings to have a grasp of the recent financials. First, revenue for the quarter came out to $111.72B, a beat of $2.06B and a 2% Y/Y improvement, while Q1 non-GAAP EPS came out to $7.23, a strong beat of 63 cents. Diving deeper, the medical cost ratio came out to 83.9%, a sight of relief for the street that was expecting 8.5% and a continued reduction from the year prior, as it stood at 84.8%. Though the operating cost increased to 13.8%, it reflects the incremental investments in people, processes, and technology, such as AI, to improve performance and support innovations. All of this pushed the management to raise its full-year guidance in terms of EPS from over $17.75 to over $18.25, as well as reaffirming strong cash generation plus confirming the $2B+ Q2 buyback authorization. Segment-wise, the Healthcare side saw an expansion in operating margin from 6.2% to 6.6% as the company took the strategy to trade membership for margin through aggressive repricing, such as the implementation of premium hikes across all lines of the business. This was a direct answer to the elevated medical cost and utilization trends that emerged in 2025. However, Optum was relatively mixed on a margin basis, as Rx stayed steady at 3.3%, Insight was strong at 15.3%, and Health was weak at 5.4%, with value-based care contracts still under pressure. On the membership side, it was down 1.1MM to 49.05MM as the firm exited unprofitable Medicare Advantage markets . Now, the Medicare Advantage side has been a main source of volatility for U...
Fudan University's Wu Xinbo, an adviser to China's Foreign Ministry, says President Xi Jinping's statement on Taiwan during a summit with President Donald Trump was a strong and direct message urging Washington to halt arms sales and explicitly oppose the island's independence. (Source: Bloomberg)
Fudan University's Wu Xinbo, an adviser to China's Foreign Ministry, says President Xi Jinping's statement on Taiwan during a summit with President Donald Trump was a strong and direct message urging Washington to halt arms sales and explicitly oppose the island's independence. (Source: Bloomberg)
Ronda Rousey says she is "smashing the record" alongside Gina Carano for the "most women have been paid in combat sports" and she could become the most powerful figure in MMA since UFC president Dana White.
Ronda Rousey says she is "smashing the record" alongside Gina Carano for the "most women have been paid in combat sports" and she could become the most powerful figure in MMA since UFC president Dana White.
Earnings Call Insights: NANO Nuclear Energy Inc. (NNE) Q2 2026 Management View "NANO Nuclear remains well positioned as a leading microreactor developer focused on vertical integration across key aspects of the nuclear fuel cycle, and we're delivering against the key strategic milestones we've outlined over the past several quarters." (Founder, Executive Chairman, President, Secretary & Treasurer ...
Earnings Call Insights: NANO Nuclear Energy Inc. (NNE) Q2 2026 Management View "NANO Nuclear remains well positioned as a leading microreactor developer focused on vertical integration across key aspects of the nuclear fuel cycle, and we're delivering against the key strategic milestones we've outlined over the past several quarters." (Founder, Executive Chairman, President, Secretary & Treasurer Jiang Yu) "Our confidence was recently validated by the formal submission of a construction permit application to the U.S. NRC under Part 50 by the University of Illinois." (Founder, Executive Chairman, President, Secretary & Treasurer Yu) "We anticipate an approximate 12-month review period following formal acceptance of the application, providing the opportunity to initiate initial construction activities at the U of I in mid- to late 2027." (CEO & Director James Walker) "From a financial perspective, our balance sheet remains strong with cash, cash equivalents and short-term investments totaling approximately $569 million." (CEO & Director Walker) "Q2 net loss totaled $9.2 million, an increase of approximately $3 million from the prior quarter." (Chief Financial Officer Jaisun Garcha) Outlook "We expect expenses to trend higher as we continue to scale our team and initiate procurement of long lead items and testing equipment in support of our engineering and demonstration facility." (Chief Financial Officer Garcha) "We anticipate an approximate 12-month review period following formal acceptance of the application" and said that timing "provid[es] the opportunity to initiate initial construction activities at the U of I in mid- to late 2027." (CEO & Director Walker) "Part 57... is going to be crucial for us because by 2030, when we have the reactor fully constructed, outputting power, licensed and ready to commercially deploy, we want to be in a position, at that point, to deploy these things en masse." (CEO & Director Walker) Financial Results "Our overall liquidity posi...
OpenAI CFO Sarah Friar says the ChatGPT maker may raise more capital even after completing what she described as the largest private fundraising round ever. She speaks with Caroline Hyde on Bloomberg Television. (Source: Bloomberg)
OpenAI CFO Sarah Friar says the ChatGPT maker may raise more capital even after completing what she described as the largest private fundraising round ever. She speaks with Caroline Hyde on Bloomberg Television. (Source: Bloomberg)